BCL2 and head and neck squamous cell carcinoma: The loss of CAF-exosomal miR-3188 could also promote HNSCC progression via the derepression of BCL2.99 Moreover, CAF-derived EVs conferred cisplatin resistance in HNSCC via miR-876-3p100 and miR-196a.101